Cargando…
ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells
BACKGROUND: Chemotherapy resistance is the leading cause of cancer treatment failure. This research was conducted to explore a potential link between actin-binding protein anillin (ANLN) and doxorubicin resistance in breast cancer. MATERIALS AND METHODS: We compared ANLN expression and 50% inhibitio...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548225/ https://www.ncbi.nlm.nih.gov/pubmed/33116832 http://dx.doi.org/10.2147/CMAR.S261828 |